×
About 1,246 results

ALLMedicine™ Hypopharyngeal Cancer Center

Research & Reviews  617 results

Incessant Atrial Tachycardia Following Combination Chemotherapy with Cetuximab, Cisplat...
https://doi.org/10.1007/s12012-021-09648-z 10.1161/01.CIR.0000133187.74800.B9 10.1016/j.ctrv.2013.03.005 10.2165/00003495-200767170-00008 10.1055/s-0033-1356164 10.3892/ol.2013.1301 10.1093/eurheartj/ehz467
Cardiovascular Toxicology; Sahashi Y, Nawa T

Apr 8th, 2021 - A 72-year-old man with stage IV hypopharyngeal cancer, who had been treated for three months with combination chemotherapy, was referred to our cardiology department for evaluation of transient palpitation. Combination therapy with cetuximab, cisp...

Oncological and Functional Outcomes of Larynx-preserving Surgery for Hypopharyngeal Can...
https://doi.org/10.4143/crt.2020.1197
Cancer Research and Treatment; Kim D, Kim N et. al.

Mar 30th, 2021 - Larynx-preserving surgery (LPS) have recently gained popularity and achieved comparable oncologic outcomes to conventional radical surgery for localized hypopharyngeal cancer (HPC). In the current study, the role of LPS has been assessed thoroughl...

Retrograde endoscopic submucosal dissection for early thoracic esophageal carcinoma.
https://doi.org/10.1007/s12328-021-01371-0 10.1016/j.anl.2006.07.012 10.1002/cncr.20974 10.1016/j.gie.2016.07.018 10.1111/den.12396 10.1002/hed.22993 10.1016/j.gie.2010.06.037 10.1111/den.13033 10.1111/den.13654 10.1007/s10388-018-0641-9 10.1007/s10388-018-0642-8 10.1007/s10388-018-0614-z 10.1093/dote/doaa092 10.2214/AJR.11.6468
Clinical Journal of Gastroenterology; Kobayashi Y, Nishikawa K et. al.

Mar 10th, 2021 - Although the standard treatment for intramucosal esophageal cancer without lymph node metastasis is endoscopic submucosal dissection (ESD), we sometimes encounter patients who are not able to undergo a transoral endoscopic examination. Here, we re...

Survival and complications with a surgical approach in advanced hypopharyngeal cancer.
https://doi.org/10.1002/jso.26440
Journal of Surgical Oncology; Galeano Machuca MP, Ng DL et. al.

Feb 23rd, 2021 - The treatment paradigm for advanced hypopharyngeal cancer has shifted from surgical approaches to organ preservation. However, recent studies indicated that surgical approaches may be associated with better survival rates. This study aimed to cond...

Nivolumab for recurrent/metastatic hypopharyngeal squamous cell carcinoma in a liver tr...
https://doi.org/10.1016/j.anl.2021.02.002
Auris, Nasus, Larynx; Kondo T, Kawachi S et. al.

Feb 22nd, 2021 - Nivolumab administration to patients with organ transplantation history requires careful management. Herein, we report the case of a living-donor liver-transplant recipient, a 52-year-old man, with recurrent and metastatic hypopharyngeal cancer tr...

see more →

Guidelines  2 results

Hypopharyngeal cancer: United Kingdom National Multidisciplinary Guidelines.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873926
The Journal of Laryngology and Otology; Pracy P, Loughran S et. al.

Nov 14th, 2016 - This is the official guideline endorsed by the specialty associations involved in the care of head and neck cancer patients in the UK. With an age standardised incidence rate of 0.63 per 100 000 population, hypopharynx cancers account for a small ...

Larynx preservation clinical trial design: key issues and recommendations-a consensus p...
https://doi.org/10.1016/j.ijrobp.2008.10.047
International Journal of Radiation Oncology, Biology, Phy... Lefebvre JL, Ang KK et. al.

Mar 24th, 2009 - To develop guidelines for the conduct of Phase III clinical trials of larynx preservation in patients with locally advanced laryngeal and hypopharyngeal cancer. A multidisciplinary international consensus panel developed recommendations after revi...

see more →

Clinicaltrials.gov  625 results

Incessant Atrial Tachycardia Following Combination Chemotherapy with Cetuximab, Cisplat...
https://doi.org/10.1007/s12012-021-09648-z 10.1161/01.CIR.0000133187.74800.B9 10.1016/j.ctrv.2013.03.005 10.2165/00003495-200767170-00008 10.1055/s-0033-1356164 10.3892/ol.2013.1301 10.1093/eurheartj/ehz467
Cardiovascular Toxicology; Sahashi Y, Nawa T

Apr 8th, 2021 - A 72-year-old man with stage IV hypopharyngeal cancer, who had been treated for three months with combination chemotherapy, was referred to our cardiology department for evaluation of transient palpitation. Combination therapy with cetuximab, cisp...

Oncological and Functional Outcomes of Larynx-preserving Surgery for Hypopharyngeal Can...
https://doi.org/10.4143/crt.2020.1197
Cancer Research and Treatment; Kim D, Kim N et. al.

Mar 30th, 2021 - Larynx-preserving surgery (LPS) have recently gained popularity and achieved comparable oncologic outcomes to conventional radical surgery for localized hypopharyngeal cancer (HPC). In the current study, the role of LPS has been assessed thoroughl...

Retrograde endoscopic submucosal dissection for early thoracic esophageal carcinoma.
https://doi.org/10.1007/s12328-021-01371-0 10.1016/j.anl.2006.07.012 10.1002/cncr.20974 10.1016/j.gie.2016.07.018 10.1111/den.12396 10.1002/hed.22993 10.1016/j.gie.2010.06.037 10.1111/den.13033 10.1111/den.13654 10.1007/s10388-018-0641-9 10.1007/s10388-018-0642-8 10.1007/s10388-018-0614-z 10.1093/dote/doaa092 10.2214/AJR.11.6468
Clinical Journal of Gastroenterology; Kobayashi Y, Nishikawa K et. al.

Mar 10th, 2021 - Although the standard treatment for intramucosal esophageal cancer without lymph node metastasis is endoscopic submucosal dissection (ESD), we sometimes encounter patients who are not able to undergo a transoral endoscopic examination. Here, we re...

Survival and complications with a surgical approach in advanced hypopharyngeal cancer.
https://doi.org/10.1002/jso.26440
Journal of Surgical Oncology; Galeano Machuca MP, Ng DL et. al.

Feb 23rd, 2021 - The treatment paradigm for advanced hypopharyngeal cancer has shifted from surgical approaches to organ preservation. However, recent studies indicated that surgical approaches may be associated with better survival rates. This study aimed to cond...

Nivolumab for recurrent/metastatic hypopharyngeal squamous cell carcinoma in a liver tr...
https://doi.org/10.1016/j.anl.2021.02.002
Auris, Nasus, Larynx; Kondo T, Kawachi S et. al.

Feb 22nd, 2021 - Nivolumab administration to patients with organ transplantation history requires careful management. Herein, we report the case of a living-donor liver-transplant recipient, a 52-year-old man, with recurrent and metastatic hypopharyngeal cancer tr...

see more →

Patient Education  2 results see all →